Phibro Animal Health CEO receives RSU stock grant

PHIBRO ANIMAL HEALTH CORP reported an equity compensation grant to President and CEO Daniel M. Bendheim.

Rhea-AI Filing Summary

PHIBRO ANIMAL HEALTH CORP reported an equity compensation grant to President and CEO Daniel M. Bendheim. He acquired 11,699 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment. Following this award, Bendheim directly holds 15,177 shares of Class A Common Stock, including the RSUs.

Insider Trade Summary

Grant/Award: 11,699 shares

Grant/Award 1 txn

Insider Bendheim Daniel M

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	11,699	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 15,177 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

Key Figures

RSUs granted: 11,699 shares Grant price: $0.00 per share Shares held after: 15,177 shares +1 more

4 metrics

RSUs granted 11,699 shares Restricted stock units awarded to Daniel M. Bendheim on 2026-08-06

Grant price $0.00 per share Equity award reported as a grant with no purchase price

Shares held after 15,177 shares Total Class A Common Stock directly held by Daniel M. Bendheim after the grant

Vesting schedule Three equal installments RSUs vest on each of the first three anniversaries of August 1, 2026

Key Terms

restricted stock units, Class A Common Stock, vest

3 terms

restricted stock units financial

"The reported securities represent restricted stock units ("RSUs"), each of which represents"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"each of which represents a contingent right to receive one share of Class A Common Stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vest financial

"The RSUs vest in substantially equal installments on each of the first three anniversaries"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PHIBRO ANIMAL HEALTH (PAHC) disclose about Daniel Bendheim’s latest equity grant?

PHIBRO ANIMAL HEALTH reported that CEO Daniel M. Bendheim received 11,699 RSUs, each convertible into one share of Class A Common Stock, as part of his equity compensation, with vesting tied to continued employment.

How many PHIBRO ANIMAL HEALTH (PAHC) shares does Daniel Bendheim hold after this Form 4?

After the reported grant, Daniel M. Bendheim directly holds 15,177 shares of PHIBRO ANIMAL HEALTH Class A Common Stock, which includes the 11,699 shares underlying his newly awarded restricted stock units.

What are the vesting terms of Daniel Bendheim’s new RSUs at PHIBRO ANIMAL HEALTH (PAHC)?

The 11,699 RSUs granted to Daniel M. Bendheim vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, conditional on his continued employment with the company through each vesting date.

Did Daniel Bendheim buy or sell PHIBRO ANIMAL HEALTH (PAHC) stock on the market?

No market purchase or sale was reported. The Form 4 shows a grant of 11,699 RSUs at a price of $0.00 per share, reflecting an equity compensation award rather than an open-market transaction.

What type of security was granted to Daniel Bendheim by PHIBRO ANIMAL HEALTH (PAHC)?

Daniel M. Bendheim received restricted stock units (RSUs), with each RSU representing a contingent right to receive one share of PHIBRO ANIMAL HEALTH Class A Common Stock, subject to the specified vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:15 PM Accepted by SEC EDGAR 08/10/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bendheim Daniel M

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	08/06/2026		A		11,699(2)	A	$0	15,177	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.

2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.

	/s/ Judith Weinstein, as Attorney-in-Fact for Daniel M Bendheim	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)